Literature DB >> 25123873

[The road to elimination: an overview of neglected infectious diseases in Latin America and the Caribbean].

Steven Kenyon Ault1, Laura Catalá Pascual1, Maria Elena Grados-Zavala1, Guillermo Gonzálvez García2, Luis Gerardo Castellanos1.   

Abstract

Neglected infectious diseases (NID) affect mainly isolated populations living in isolation and in poor socioeconomic conditions. These diseases, by their chronic and silent nature, often affect communities with a weak political voice. This translates into very little attention or political priority; which is reflected in minimal and insufficient preventive measures, monitoring and control. However, there is evidence this situation is changing favorably in some countries of the Americas. In recent years, several resolutions (official agreement of the member countries of the Pan American Health Organization / World Health Organization-PAHO / WHO), regional and global agreements on public health; with a greater commitment from the pharmaceutical industry, and other donors and international partners in combination with the development and use of integrated action plans have allowed countries to intensify public interventions to control these diseases and thus achieve target elimination of NID. Onchocerciasis, lymphatic filariasis, Chagas disease, leprosy and trachoma blindness, among others, have been eliminated in several countries and endemic areas, regardless of the level of development of the country or geographical area where they are located. The political decision reflected in adequate financial resources in the next decade will be crucial to achieving the goals of elimination of NID (regional and national).

Entities:  

Mesh:

Year:  2014        PMID: 25123873

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  1 in total

1.  Epidemiology of Tropical Neglected Diseases in Ecuador in the Last 20 Years.

Authors:  Monica Cartelle Gestal; Alina Maria Holban; Santiago Escalante; Marcelo Cevallos
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.